Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The current study is a prospective phase II study; Eligible patients will receive hypofractionated Irradiation at a total dose of 28.5Gy in 5 once-weekly fractions of 5.7Gy in 5 weeks to the Whole Breast or chest wall with or without peripheral lymphatic irradiation.
Epistemonikos ID: bc0e61a5398c2c09f84d246d2c811229ade2869f
First added on: May 07, 2024